VivoSeq
Other

Liver Resection

0

Pipeline Programs

4

Active Trials

0

Companies Involved

Liver Resection is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

63/100

Attrition Rate

26/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

27

clinical trials

Completed12 · 44%
Terminated7 · 26%
Unknown status4 · 15%
Recruiting3 · 11%
Not yet recruiting1 · 4%

Trial Activity

27 trials

A Trial of Licartin for Preventing Tumor Recurrence After Liver Resection
Completed··Phase 2·NCT00819650·200 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)